mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.2 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |